Cargando…
The Role of mTOR and eIF Signaling in Benign Endometrial Diseases
Adenomyosis, endometriosis, endometritis, and typical endometrial hyperplasia are common non-cancerous diseases of the endometrium that afflict many women with life-impacting consequences. The mammalian target of the rapamycin (mTOR) pathway interacts with estrogen signaling and is known to be dysre...
Autores principales: | Driva, Tatiana S., Schatz, Christoph, Sobočan, Monika, Haybaeck, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998789/ https://www.ncbi.nlm.nih.gov/pubmed/35408777 http://dx.doi.org/10.3390/ijms23073416 |
Ejemplares similares
-
Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis
por: Driva, Tatiana S., et al.
Publicado: (2023) -
The Interplay of Tumor Stroma and Translational Factors in Endometrial Cancer
por: Sobočan, Monika, et al.
Publicado: (2020) -
The Communication between the PI3K/AKT/mTOR Pathway and Y-Box Binding Protein-1 in Gynecological Cancer
por: Sobočan, Monika, et al.
Publicado: (2020) -
mTOR inhibitor efficacy is determined by the eIF4E/4E-BP ratio
por: Alain, Tommy, et al.
Publicado: (2012) -
eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway
por: Sun, Liping, et al.
Publicado: (2021)